Article
Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantation
2 Jun 2018
Abstract excerpt
OBJECTIVES: Quality of life (QoL) has become an important tool to guide decision making in oncology. Given the heterogeneity among hematological cancer survivors, however, clinicians need comparative data across different subsets. METHODS: This study recruited survivors of hematological malignancies (≥2.5 years after diagnosis) from 2 German cancer registries. QoL was assessed with the EORTC QLQ-C30. The sample...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
